HF
SHPH icon

HRT Financial’s Shuttle Pharmaceuticals SHPH Stock Holding History

HRT Financial’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Buy
+78,597
New +$514K ﹤0.01% 3230
2024
Q4 		– Sell
-103
Closed -$34K – 3139
2024
Q3 		$34K Buy
+103
New +$63.2K ﹤0.01% 2145

Other funds holding SHPH

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
KFA
Kelleher Financial Advisors New York $705M AUM 16.14% 1-Year Est. Return

HRT Financial's SHPH Position: Q2 2026 in Review

HRT Financial opened a new position in Shuttle Pharmaceuticals (SHPH) in Q2 2026: 78,597 shares worth $255K. The stake represents ﹤0.01% of the portfolio and ranks #3230 among its holdings. This is a return to the name: HRT Financial previously reported a position in SHPH as recently as Q3 2024.

HRT Financial first reported a position in SHPH in Q3 2024 and has held it in 2 quarters since. 5 funds tracked by Wall St. Rank hold SHPH as of Q2 2026.

  • HRT Financial held 78,597 shares of Shuttle Pharmaceuticals worth $255K as of Q2 2026.
  • Shuttle Pharmaceuticals was a new HRT Financial position in Q2 2026.
  • Shuttle Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3230 holding.
  • HRT Financial first reported a position in Shuttle Pharmaceuticals in Q3 2024 and has held it in 2 quarters since.
  • 5 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.